Anouk De Vroey retweeted
I am proud that @JanssenEMEA is investing in its first European production site for innovative #celltherapy in Ghent, Belgium🇧🇪. The state-of-the-art facilities will produce CAR-T therapy for the treatment of cancer. janssen.com/belgium/janssen-…
Anouk De Vroey retweeted
♻️Plant-on-a-Truck was developed by @JanssenEMEA & @inopsysnv: water layers that can’t be sent to water treatment works are treated onsite, allowing to reuse useful materials. Read more:
bit.ly/371Uxlu
#WeWontRest
Anouk De Vroey retweeted
We discussed the many challenges we share as allies:
• Tackling the pandemic, preparing the world for future ones
• Protecting our climate
• Setting up a Trade & Tech Council
• Supporting democracy in the world
Anouk De Vroey retweeted
Our digital working group's recommendations are being discussed at the #DHSSummit2020. Moderated by the group's chair @bleddyn_rees & featuring:
🟣@eupatientsforum's @micheclb
🟣@medtecheurope's @mstrubin
🟣@JNJNews' Francesco Buonarroti
➡️echalliance.com/digital-heal…
#HealthyEurope
Anouk De Vroey retweeted
LIVE, today Anouk De Vroey joins Mario Monti @SenatoreMonti with @POLITICOEurope panel to discuss Health care systems post-COVID 19: Pressing Reset #POLITICOHCsystems Check out Anouk's latest publication: politi.co/37OGXDu
Anouk De Vroey retweeted
As coronavirus spreads rapidly across Europe, we are securing doses of future vaccine to protect citizens.
Today we signed a contract with #JNJ 📄🖊
It enables EU countries to buy up to 400 million doses.
This is our 3rd contract with a pharma company. More will follow.
Anouk De Vroey retweeted
Helping others while keeping fit? That's our plan for this weekend! Every kilometre cycled in our annual #cycle4children event helps @sos_children provide psychological support to children effected by the current pandemic. Happy Cycling everyone!
Anouk De Vroey retweeted
EFPIA’s #ConnectingHealthcare shows the power of collaboration and partnerships when it comes to improving lives of patients worldwide. #HONEUR is a great example of a collaborative platform to better share blood cancer patient data. For more info: bit.ly/2YgsZTl
Anouk De Vroey retweeted
Did you know that there are currently over 7,000 medicines in development? #WeWontRest bit.ly/2rAfKyU
Anouk De Vroey retweeted
"At Johnson & Johnson, we believe human health and environmental health are inextricably linked." – #JNJ's Alex Gorsky #CarbonDividends teapaw.org/TheCLCouncil/status/87…
Thanks to our Founding Members for their vision and leadership. Time for a consensus climate solution. clcouncil.org/founding-membe…
Anouk De Vroey retweeted
No one single stakeholder can tackle market access - has to be collaborative @NABedlington @eupatientsforum #EFPIA2017
Anouk De Vroey retweeted
We need to get innovation in the right areas and solve inequity in access to it across Europe - Martin Seychell @EU_Health #EFPIA2017
Anouk De Vroey retweeted
Talking #Brexit: Seychell "Need to make sure EMA will re-locate without too many staff loses and as soon as possible" #EFPIA2017 @EFPIA
Anouk De Vroey retweeted
Intellectual property is the foundation that enables innovative ideas to be developed into medicines #EFPIA2017 #IP #innovation
Anouk De Vroey retweeted
If Britain changes its mind, it will find an open door but it will be a new door to a new Europe.
Anouk De Vroey retweeted
New collaborative mindset needed on a pragmatic, ethical and transparent basis #EFPIA2017 Tks Sec General @eupatientsforum @NABedlington
Anouk De Vroey retweeted
Martin Seychell @EU_Health calls for innovation in our healthcare models...we need to intervene earlier in treating disease #EFPIA2017
Anouk De Vroey retweeted
EFPIA President Stefan Oschmann @merckgroup innovation depends upon a strong incentives framework #EFPIA2017 #WeWontRest
Anouk De Vroey retweeted
Europe invested 30 Bn euros in #R&D (Belgium: 2.89 Bn) to unlock tomorrow's cures @EFPIA President S. Oschmann: "I assure you, #wewontrest "
Anouk De Vroey retweeted
That's why @IMI_JU is so important! Antimicrobial Resistance: PPPs The Way Forward @EFPIA ip-watch.org/2017/05/25/anti… via @ipwatch





















